Proto Labs (PRLB) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue reached $125.6 million, up 2.8% year-over-year, with Protolabs Network revenue up 22% to $24.7 million and growth in both U.S. and European segments.

• Net income for Q2 2024 was $4.5 million ($0.18 per diluted share), up from a net loss of $0.4 million in Q2 2023; non-GAAP net income was $9.5 million ($0.38 per share).

• Gross margin improved to 45.0% (GAAP) and 45.7% (non-GAAP), reflecting cost controls, automation, and margin expansion.

• Strategic focus remains on increasing adoption of the comprehensive offer, driving higher revenue per customer through larger orders, and expanding the digital manufacturing network.

• Major organizational restructuring separates revenue generation from operations, eliminates regional general manager roles, and creates a global operations organization.

Financial highlights

• Q2 2024 revenue: $125.6 million, up 2.8% year-over-year; Protolabs Network revenue: $24.7 million, up 22% year-over-year.

• Non-GAAP gross margin for Q2 was 45.7%; GAAP gross margin was 45.0%.

• Non-GAAP diluted EPS for Q2 was $0.38, at the top end of expectations; net income was $4.5 million ($0.18 per share).

• Cash flow from operations was $14.4 million; cash and investments totaled $112.9 million at quarter-end.

• $10.9 million in share repurchases during Q2; $61.4 million remains under the current repurchase authorization.

Outlook and guidance

• Q3 2024 revenue is expected between $117 million and $125 million, with non-GAAP EPS projected between $0.29 and $0.37.

• Guidance includes $500,000 in one-time reorganization costs and anticipates a non-GAAP effective tax rate of 22%-23%.

• Gross margin and operating expenses are expected to be down slightly quarter-over-quarter at the midpoint of guidance.

• Foreign currency expected to have a $200,000 favorable impact on Q3 revenue.

• Existing cash and cash flow from operations are expected to meet working capital and capital expenditure needs for at least the next 12 months.